HomeALPN • NASDAQ
add
Alpine Immune Sciences Inc
Previous close
$64.96
Day range
$64.97 - $65.00
Year range
$8.33 - $65.00
Market cap
4.46B USD
Avg Volume
3.50M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 7.03M | -25.09% |
Operating expense | 7.27M | 34.70% |
Net income | -17.92M | -35.07% |
Net profit margin | -254.81 | -80.31% |
Earnings per share | -0.28 | 0.00% |
EBITDA | -22.55M | -45.93% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 305.66M | 56.81% |
Total assets | 373.65M | 42.56% |
Total liabilities | 40.94M | -55.76% |
Total equity | 332.70M | — |
Shares outstanding | 68.60M | — |
Price to book | 12.79 | — |
Return on assets | -15.06% | — |
Return on capital | -16.68% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -17.92M | -35.07% |
Cash from operations | -27.69M | -5.88% |
Cash from investing | -2.56M | -109.04% |
Cash from financing | 19.35M | 1,880.22% |
Net change in cash | -10.90M | -1,101.38% |
Free cash flow | -19.82M | -165.50% |
About
Founded
2007
Headquarters
Website
Employees
142